V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220020628 | 220013883 | 0 | 61 | Curative (C) | 2016-11-25 | 2017-01-17 | AML18 PILOT TRIAL | 01 | null | 220026988 | PILOT TRIAL |
| 220020629 | 220007056 | 1.87 | null | Disease modification (D) | 2015-03-22 | 2015-03-30 | Dasatinib | 02 | N | 220027014 | DASATINIB |
| 220020630 | 220007059 | 1.76 | null | Curative (C) | 2019-01-18 | 2019-02-18 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027025 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020631 | 220007065 | null | 66.6 | Curative (C) | 2018-03-28 | 2018-03-28 | AML 18 TRIAL | 1 | null | 220027042 | AML18 TRIAL |
| 220020632 | 220007068 | 1.68 | 103 | Palliative (P) | 2015-01-19 | 2015-03-14 | AML 18 TRIAL | 1 | N | 220027059 | AML18 TRIAL |
| 220020634 | 220007077 | 0 | 82.2 | Disease modification (D) | 2017-03-27 | 2018-04-02 | Dasatinib | N | N | 220027135 | DASATINIB |
| 220020635 | 220007080 | 0 | 78.1 | Curative (C) | 2017-02-09 | 2017-02-14 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | null | 220027145 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020636 | 220007089 | null | 65.4 | Disease modification (D) | 2016-10-27 | 2016-11-03 | AML 18 Pilot Trial | 1 | N | 220027179 | PILOT TRIAL |
| 220020637 | 220007099 | 1.61 | 65.7 | Curative (C) | 2016-08-24 | 2017-08-13 | Rituximab | N | N | 220027227 | RITUXIMAB |
| 220020638 | 220007100 | 1.75 | 74.3 | Curative (C) | 2018-05-22 | 2018-05-24 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | null | 220027231 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020639 | 220007113 | 1.67 | 90.4 | null | 2016-09-29 | 2016-10-20 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027295 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020640 | 220007120 | 1.67 | 70 | Curative (C) | 2015-02-27 | 2015-03-03 | AML 18 TRIAL | 1 | N | 220027314 | AML18 TRIAL |
| 220020641 | 220007140 | 1.65 | null | Curative (C) | 2017-10-22 | 2017-10-22 | Dasatinib | N | null | 220027407 | DASATINIB |
| 220020642 | 220007149 | 1.62 | 54.7 | Curative (C) | 2017-01-18 | 2017-01-19 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027456 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020643 | 220017590 | 1.76 | 77.3 | Disease modification (D) | 2016-11-12 | 2016-11-13 | Rituximab | N | N | 220027491 | RITUXIMAB |
| 220020644 | 220017590 | 1.71 | 44.2 | Curative (C) | 2016-09-27 | 2016-10-14 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220027491 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020645 | 220013949 | 1.76 | 95.5 | Curative (C) | 2014-01-14 | 2014-02-13 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220027516 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020646 | 220007164 | 0 | null | null | 2015-11-14 | 2016-09-12 | Dasatinib | null | N | 220027518 | DASATINIB |
| 220020647 | 220007167 | 166.9 | 127 | Curative (C) | 2015-05-20 | 2015-05-20 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027534 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020648 | 220013953 | 1.32 | 65.8 | Palliative (P) | 2014-02-14 | 2014-02-14 | Dasatinib | 2 | N | 220027551 | DASATINIB |
| 220020649 | 220007175 | 1.63 | 64 | Curative (C) | 2016-06-08 | 2016-07-18 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027553 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020650 | 220013956 | 1.49 | 111.5 | Curative (C) | 2013-11-13 | 2014-09-07 | Dasatinib | N | N | 220027583 | DASATINIB |
| 220020651 | 220007182 | 1.7 | null | null | 2014-04-17 | 2014-04-23 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027594 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020652 | 220007197 | 1.75 | 66 | Curative (C) | 2015-05-24 | 2015-05-31 | AML 18 TRIAL | N | N | 220027658 | AML18 TRIAL |
| 220020653 | 220007201 | 1.67 | 67 | Disease modification (D) | 2014-03-22 | 2015-01-04 | Dasatinib | 2 | N | 220027659 | DASATINIB |
| 220020654 | 220007205 | 1.64 | 80.5 | Disease modification (D) | null | 2015-11-08 | AML 18 TRIAL | N | N | 220027665 | AML18 TRIAL |
| 220020655 | 220019647 | null | 54.7 | Curative (C) | 2015-01-14 | 2015-01-21 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027691 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020656 | 220007217 | 1.7 | 86 | Curative (C) | 2016-04-03 | 2016-04-07 | AML 18 TRIAL | Y | N | 220027703 | AML18 TRIAL |
| 220020657 | 220007231 | 1.85 | 116.8 | Curative (C) | 2016-10-14 | 2017-01-18 | AML 18 TRIAL | null | N | 220027754 | AML18 TRIAL |
| 220020658 | 220007234 | 1.68 | 82 | Curative (C) | 2013-11-08 | 2013-11-08 | Dasatinib | 02 | N | 220027773 | DASATINIB |
| 220020659 | 220007241 | 1.62 | 90.1 | Curative (C) | 2013-06-30 | 2013-07-09 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220027806 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020660 | 220007248 | 1.54 | 84.2 | Curative (C) | 2017-06-16 | 2017-08-05 | Dasatinib | 2 | N | 220027816 | DASATINIB |
| 220020661 | 220007258 | 1.6 | 44.2 | Curative (C) | 2017-12-19 | 2017-12-19 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027861 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020662 | 220007266 | 1.8 | 86 | Curative (C) | 2015-05-29 | 2015-06-02 | AML 18 TRIAL | Y | N | 220027906 | AML18 TRIAL |
| 220020663 | 220007269 | 1.68 | 50.4 | Curative (C) | 2017-10-27 | 2017-10-27 | Alemtuz+Fludara+Melphalan RIC MUD | null | Y | 220027908 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020664 | 220017625 | 0 | 63 | Disease modification (D) | 2016-04-02 | 2016-05-09 | AML 18 Pilot Trial | Y | null | 220027940 | PILOT TRIAL |
| 220020665 | 220020843 | null | 94.2 | Curative (C) | 2017-12-01 | 2017-12-01 | Rituximab | 2 | N | 220027944 | RITUXIMAB |
| 220020666 | 220007282 | null | 61.8 | Palliative (P) | 2015-05-15 | 2015-07-08 | AML 18 TRIAL | Y | N | 220027982 | AML18 TRIAL |
| 220020667 | 220007297 | 1.73 | 77.7 | Disease modification (D) | 2017-01-26 | 2017-02-05 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028118 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020668 | 220007298 | 1.73 | 90 | Curative (C) | 2016-10-23 | 2016-10-23 | Rituximab (Maintenance) | N | N | 220028118 | RITUXIMAB |
| 220020669 | 220007300 | 1.79 | 73.2 | Curative (C) | 2013-05-17 | 2013-08-15 | AML 18 TRIAL | N | N | 220028136 | AML18 TRIAL |
| 220020670 | 220007304 | 1.85 | 89.2 | Disease modification (D) | 2016-12-21 | 2017-04-14 | Dasatinib | N | N | 220028139 | DASATINIB |
| 220020671 | 220014023 | 1.67 | 73 | Curative (C) | 2014-10-22 | 2014-10-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028151 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020672 | 220007312 | 1.76 | 80.1 | Disease modification (D) | 2013-11-12 | 2013-11-15 | Rituximab | N | N | 220028170 | RITUXIMAB |
| 220020674 | 220021508 | 1.58 | 64.6 | null | 2015-02-26 | 2015-05-07 | AML 18 TRIAL | N | N | 220028201 | AML18 TRIAL |
| 220020675 | 220022207 | 1.75 | 89.5 | Curative (C) | 2016-03-08 | 2016-03-20 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028203 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020676 | 220007322 | 0 | 73.7 | Curative (C) | 2017-10-10 | 2017-10-25 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220028206 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020677 | 220007325 | 1.8 | 77 | Adjuvant (A) | 2018-08-16 | 2018-08-16 | Dasatinib | N | N | 220028231 | DASATINIB |
| 220020678 | 220014038 | 1.82 | 84.9 | Curative (C) | 2013-08-22 | 2013-09-10 | Rituximab (Maintenance) | N | N | 220028246 | RITUXIMAB |
| 220020679 | 220007338 | 1.75 | 64.6 | Curative (C) | null | 2018-05-08 | AML 18 Pilot Trial | Y | N | 220028292 | PILOT TRIAL |